Superficial dermatophyte (and Malassezia) infections of skin, hair, and nails with site-specific presentations.
Also known as: tinea, ringworm, dermatophytosis, athlete's foot, jock itch, tinea versicolor, pityriasis versicolor
Overview
Superficial fungal infections of keratinized tissue. Dermatophyte tineas (Trichophyton, Microsporum, Epidermophyton) cause classic ringworm of body (corporis), scalp (capitis), feet (pedis), groin (cruris), hands (manuum), and nails (unguium/onychomycosis). Tinea versicolor (pityriasis versicolor) is caused by Malassezia furfur — a yeast, not a true dermatophyte.
Epidemiology
Tinea pedis is the most common dermatophytosis worldwide (~10% point prevalence). Tinea capitis predominantly affects prepubertal children, especially Black children in the US (Trichophyton tonsurans). Tinea versicolor is common in adolescents and young adults in humid climates.
🔒 Free preview limit reached
Keep reading — start your free trial
You've read your 2 free diagnosis previews. Create your free account to unlock the full Tinea Infections (corporis, capitis, pedis, cruris, versicolor) outline — plus all 514 diagnoses, 3,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.
Family member with tinea capitis (shared combs, hats)
Pathophysiology
Dermatophytes secrete keratinases that allow invasion of stratum corneum, hair, and nail. Inflammation results from host immune response; minimal inflammation in immunosuppressed → 'tinea incognito' under steroids. Malassezia is a lipophilic yeast colonizing sebaceous skin; conversion from yeast to mycelial form produces clinical pityriasis versicolor; azelaic acid produced by the organism inhibits melanocytes (hypopigmentation).
Clinical presentation
Symptoms
Pruritus (mild to moderate)
Scalp scaling, hair loss (capitis)
Burning, fissuring between toes (pedis)
Cosmetic concerns (versicolor)
Signs / physical exam
Tinea corporis: annular erythematous plaque with raised scaly active border and central clearing; satellite lesions if extensive
Tinea capitis: scaly patches with broken hairs ('black dot' pattern from endothrix T. tonsurans); kerion = boggy inflammatory mass with pustules and lymphadenopathy; favus = yellow scutula crusts
Onychomycosis: yellow/white nail discoloration, subungual hyperkeratosis, onycholysis, dystrophy (distal subungual most common)
Tinea versicolor: hypo- or hyperpigmented finely scaling macules and patches on upper trunk, neck, shoulders; 'fawn-colored' or pink in untanned skin
Classic findings
Active raised scaly border with central clearing (corporis); KOH 'spaghetti and meatballs' (versicolor); Wood's lamp yellow-green fluorescence (Microsporum tinea capitis).
Differential diagnosis
Nummular eczema — Coin-shaped, no central clearing, KOH negative
Psoriasis — Silvery scale, extensor surfaces, nail pitting
Seborrheic dermatitis — Greasy scale in seborrheic distribution
Erythrasma (groin/folds) — Coral-red Wood's lamp fluorescence (Corynebacterium minutissimum); thin brown patches; treat with erythromycin/clindamycin
Granuloma annulare — Smooth annular skin-colored to violaceous papules without scale; KOH negative
Alopecia areata (vs tinea capitis) — Smooth bald patches without scale, exclamation point hairs, no broken hairs at scalp; KOH/culture negative
Vitiligo (vs tinea versicolor) — Complete depigmentation, no scale, Wood's lamp bright milky white fluorescence
Diagnostic workup
Diagnostic criteria
KOH and/or culture positivity in characteristic clinical setting.
Labs
KOH preparation of scale or hair: branching septate hyphae (dermatophyte) or short hyphae + spores ('spaghetti and meatballs') for versicolor
Fungal culture (Sabouraud or DTM agar) — confirms species, especially for capitis and onychomycosis before systemic therapy
Wood's lamp: blue-green fluorescence with Microsporum tinea capitis (T. tonsurans is non-fluorescent); pale yellow with versicolor; coral-red with erythrasma
PAS-stained nail clipping or PCR for onychomycosis diagnosis
Baseline LFTs before oral terbinafine or itraconazole
Imaging
Not indicated
Diagnostic algorithm
Variant
Site / Lesion
Preferred Therapy
Corporis (ringworm)
Annular plaque, raised scaly border, central clearing
Topical azole or terbinafine 2-4 wks
Capitis
Scaly scalp, broken hairs, ± kerion
Oral terbinafine or griseofulvin × 4-8 wks + antifungal shampoo
Pedis
Interdigital maceration; moccasin hyperkeratosis
Topical terbinafine; oral if moccasin/extensive
Cruris
Inguinal scaly plaques sparing scrotum
Topical azole or terbinafine
Onychomycosis
Yellow nail, subungual debris, onycholysis
Oral terbinafine 6 wks (fingers) / 12 wks (toes)
Versicolor
Hypo/hyperpigmented finely scaling macules on trunk
Selenium sulfide or ketoconazole shampoo; oral itraconazole if extensive
Tinea capitis (REQUIRES SYSTEMIC): oral griseofulvin (microsize) 20-25 mg/kg/day × 6-8 weeks (preferred for Microsporum) OR oral terbinafine 3-6 mg/kg/day × 4-6 weeks (preferred for Trichophyton tonsurans, more common in US); adjunctive selenium sulfide or ketoconazole shampoo 2-3x/wk reduces shedding and transmission
Onychomycosis: oral terbinafine 250 mg daily × 6 weeks (fingernails) or 12 weeks (toenails) — most effective; alternatives: itraconazole pulse, fluconazole weekly; topical efinaconazole or tavaborole if oral contraindicated
Tinea versicolor: topical selenium sulfide 2.5% lotion, ketoconazole 2% shampoo, or clotrimazole — lather, leave 10 min, rinse — daily × 1-2 weeks; or oral itraconazole 200 mg/day × 5-7 days for widespread/refractory (avoid oral fluconazole single-dose regimens that were once popular — relapse common)
Kerion (inflammatory tinea capitis)
Oral antifungal (terbinafine or griseofulvin) PLUS short course oral prednisone 0.5-1 mg/kg/day × 5-10 days to reduce scarring alopecia
Antibiotic only if bacterial superinfection — DO NOT drain kerion (sterile inflammation)
Tinea incognito (steroid-modified)
Discontinue topical corticosteroid
Treat with appropriate antifungal — often requires systemic therapy because of extensive subclinical spread
Second-line / adjunct
Avoid systemic ketoconazole due to hepatotoxicity and adrenal suppression risk (FDA boxed warning)
Recheck culture and consider drug resistance (e.g., Trichophyton indotineae — emerging terbinafine-resistant species)
Counsel on hygiene: clean and dry skin folds, antifungal foot powder, change socks, treat shoes with antifungal spray
Complications
Scarring alopecia from untreated kerion
Bacterial superinfection (impetigo, cellulitis), especially with maceration
Onychomycosis: chronic relapsing course, gateway for cellulitis in diabetics
Id reaction (autoeczematization): vesicular dermatitis on hands during active tinea pedis — sterile, immune-mediated
Terbinafine adverse effects: hepatotoxicity, taste disturbance, drug interactions (CYP2D6)
Tinea cruris spares the scrotum; candida intertrigo involves the scrotum with satellite pustules — quick distinguishing feature.
Pruritic annular plaque with central clearing and active border = tinea corporis until proven otherwise — KOH first, treat empirically only if KOH unavailable.
NEVER use topical betamethasone/clotrimazole combination (Lotrisone) — the steroid potency is too high for the skin folds where it is commonly used; causes atrophy and tinea incognito.
Tinea capitis is the only superficial fungal infection that REQUIRES systemic therapy — topicals will not penetrate hair shaft.
Tinea versicolor responds to therapy but pigment changes can take months to fade — counsel patients to avoid attributing relapse to treatment failure.
References
AAD 2014 — Guidelines of Care for Superficial Mycotic Infections of the Skin: Tinea Corporis, Tinea Cruris, Tinea Pedis (Drake et al.; updated standards)
Cochrane 2016 — Systemic Antifungal Therapy for Tinea Capitis in Children (Chen et al., Cochrane Database Syst Rev 2016)
AAFP 2014 — Diagnosis and Management of Tinea Infections (Ely, Rosenfeld, Stone, Am Fam Physician 2014)
Practice Dermatology questions on FirstPassPA
Turn this outline into retention. 3,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.
Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants.